Skip to content

Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE

Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05601206
Acronym
CARES-Lite
Enrollment
40
Registered
2022-11-01
Start date
2028-01-14
Completion date
2032-06-01
Last updated
2026-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Depression, Fatigue, Pain, Sleep

Keywords

Cancer Depression Fatigue Pain

Brief summary

To test the efficacy of a web-based stepped collaborative care intervention to reduce symptoms of depression, pain, and fatigue and improve health-related quality of life (HRQL) in advanced cancer patients and to reduce stress and depression, and fewer CVD risk factors in caregivers.

Detailed description

The intervention is designed to maintain quality of life for those in greatest need and least access to resources. This innovative and scalable web-based collaborative care intervention is expected not only to improve patients' quality of life, at the end of life, but also reduce caregiver stress and depression, and potentially health morbidity and mortality of patients and spousal and intimate partner caregivers from socioeconomically disadvantaged backgrounds. Study findings are expected to lead to research examining the dissemination and implementation of the intervention.

Interventions

Using website that was specifically designed for advanced cancer patient, collaborative with treatment from health professional

BEHAVIORALEnhanced Usual Care

Usual care from health providers

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
21 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients: Biopsy and/or radiograph proven diagnosis of hepatocellular carcinoma, cholangiocarcinoma, gallbladder carcinoma or breast, ovarian, or colorectal cancer with liver metastases with a life expectancy of at least one year; age \>21 years; no evidence of thought disorder, delusions, or active suicidal ideation is observed or reported. * Caregivers: A spouse or cohabitating intimate partner of an advanced cancer patient being evaluated the UPMC's Liver Cancer Center and age \>21 years

Exclusion criteria

* Patients: Age \< 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation. * Caregivers: Age \< 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation.

Design outcomes

Primary

MeasureTime frameDescription
Sleep QualityChange from baseline at 6 monthsPittsburgh Sleep Quality Index (PSQI)
Pain LevelChange from baseline at 6 monthsBrief Pain Inventory (BPI)
FunctioningChange from baseline at 6 monthsFunctional Assessment for Cancer Therapy Hepatobiliary (FACT - Hep)
DepressionChange from baseline at 6 monthsCenter for Epidemiological Studies -Depression (CESD)
StressChange from baseline at 6 monthsPerceived Stress Scale (PSS)
FatigueChange from baseline at 6 monthsFunctional Assessment for Cancer Therapy Fatigue (FACT - Fatigue)
Caregiver Quality of LifeChange from baseline at 6 monthsCaregiver Quality of Life Questionnaire (CQOL)

Countries

United States

Contacts

CONTACTJennifer L Steel, PhD
steeljl@upmc.edu14126922041
PRINCIPAL_INVESTIGATORJennifer L Steel

UPMC Department of Surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 10, 2026